Stay alert, beware of scamsters - know more
1D
1W
1M
1Y
3Y
5Y
Max
Open2,338.8
High2,397.5
Low2,335
Prev. Close2,339.4
Avg. Traded Price2,368.11
Volume1,51,730

MARKET DEPTH

info2
Total bid99.00
Total ask0.00
OrdersQtyBid
2992339.4
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

₹2335.0014 hours ago
₹2397.5019 hours ago
arrow

LOWER/UPPER CIRCUITS

₹2105.00
₹2572.60
arrow
Emcure Pharmaceuticals Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 15.73%, in the last year to ₹9,216.2 Cr. Its sector's average revenue growth for the last fiscal year was 12.19%.
noteAnnual Net Profit,rose 35.67% in the last year to ₹924.36 Cr. Its sector's average net profit growth for the last fiscal year was 1.94%.
notePrice to Earning Ratio,is 40.58, lower than its sector PE ratio of 43.58.
View more
personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

Emcure Pharmaceuticals Ltd has delivered 67.76% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹2,395.00 on 13 Nov 2026 and a 52-week low of ₹1,312.30 on 26 Nov 2025. It is currently trading at ₹2,339.40 as of 17 Nov 2026.

The all-time high (ATH) for Emcure Pharmaceuticals Ltd was ₹2,361.70, recorded on 13 Nov 2026. At the current price of ₹2,339.40, the stock is trading 0.94% below its all-time high. The all-time low recorded was ₹905.60 on 09 Apr 2025.

The intraday high for Emcure Pharmaceuticals Ltd on the NSE today (17 Nov 2026) was ₹2,397.50. This compares to the 52-week high of ₹2,395.00 recorded on 13 Nov 2026. Today's high was 0.10% above the 52-week high.

The intraday low for Emcure Pharmaceuticals Ltd on the NSE today was ₹2,335.00. The stock's 52-week low stands at ₹1,312.30, recorded on 26 Nov 2025. Today's low is 77.93% above the 52-week low, indicating the stock is trading well above its yearly lows.

As of 17 Nov 2026, the share price of Emcure Pharmaceuticals Ltd is ₹2,339.40 on the NSE and ₹2,332.85 on the BSE. The stock opened at ₹2,338.80, touched a high of ₹2,397.50 and a low of ₹2,335.00 during today's session.

Over the last 6 months, Emcure Pharmaceuticals Ltd has given a return of 38.70%. The stock was priced at ₹1,686.20 on 18 May 2026 and has Rise to ₹2,339.40 as of 17 Nov 2026, a change of ₹653.20 per share.

Emcure Pharmaceuticals Ltd has delivered a return of 24.81% over the last 3 months. The stock was trading at ₹1,873.90 on 17 Aug 2026 and is currently at ₹2,339.40 as of 17 Nov 2026, reflecting a Gain of ₹465.50 per share over this period.

Emcure Pharmaceuticals Ltd has delivered a N/A% absolute return over the past 5 years, equivalent to a CAGR of N/A% per annum. The stock was priced at ₹N/A in Nov 2021 and has fallen to ₹2,339.40 as of 17 Nov 2026. An investment of ₹1,00,000 in Emcure Pharmaceuticals Ltd five years ago would be worth ₹N/A today.

No,Emcure Pharmaceuticals Ltd has not declared any dividend over the past 5 years. The company paid a total dividend of 6.60 per share between FY2022 and FY2026, with the most recent dividend of ₹3.60 per share for May 26, with an ex-dividend date of 04 Sep 2026. At the current market price of ₹2,339.40, the trailing dividend yield of Emcure Pharmaceuticals Ltd stands at 3.60%.

For Q2 FY27, Emcure Pharmaceuticals Ltd reported: Revenue (Net Sales): ₹16679.84 Cr - Up 14.96% year-on-year from ₹14509.31 Cr in Q1 FY27. Net Income (PAT): ₹2484.28 Cr - Up 24.15% year-on-year from ₹2001.08 Cr in Q1 FY27.

+91
Offer Banner Trigger
Offer Banner

Open a FREE Demat Account

+91